Contact Us    855-RIA-PLAN (855-742-7526)

LLY: Eli Lilly And Co Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 210,343.53
Enterprise Value ($M) 223,945.63
Book Value ($M) 6,663.50
Book Value / Share 7.35
Price / Book 31.57
NCAV ($M) -23,850.00
NCAV / Share -26.31
Price / NCAV -8.82

Profitability (mra)
Return on Invested Capital (ROIC) 0.26
Return on Assets (ROA) 0.14
Return on Equity (ROE) 1.42

Liquidity (mrq)
Quick Ratio 0.89
Current Ratio 1.15

Balance Sheet (mrq) ($M)
Current Assets 17,295.50
Assets 47,809.00
Liabilities 41,145.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Pnc Financial Services Group, Inc. 5.44 -0.23
02-10 13G/A Vanguard Group Inc 7.18 -3.18
01-29 13G/A BlackRock Inc. 6.10 -3.40
01-21 13G/A Lilly Endowment Inc 11.62 -23.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 COMMISSION FILE NUMBER 001-6351 ELI
2021-04-30 10-Q Quarterly Report – 10-Q
2021-02-17 10-K Annual Report – 10-K
2020-10-28 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-09-24 153,470 1,188,700 12.91
2021-09-23 164,279 1,586,979 10.35
2021-09-22 158,168 1,893,554 8.35
2021-09-21 140,437 1,766,251 7.95
2021-09-20 288,567 2,270,906 12.71

(click for more detail)

(click for list of largest short owners)

Similar Companies
GSK – GlaxoSmithKline plc JNJ – Johnson & Johnson
LCI – Lannett Company, Inc. MRK – Merck & Co., Inc.
MYOV – Myovant Sciences Ltd.


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts